GB0613952D0 - Antiviral agent - Google Patents

Antiviral agent

Info

Publication number
GB0613952D0
GB0613952D0 GB0613952A GB0613952A GB0613952D0 GB 0613952 D0 GB0613952 D0 GB 0613952D0 GB 0613952 A GB0613952 A GB 0613952A GB 0613952 A GB0613952 A GB 0613952A GB 0613952 D0 GB0613952 D0 GB 0613952D0
Authority
GB
United Kingdom
Prior art keywords
antiviral agent
antiviral
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0613952A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge University Technical Services Ltd CUTS
Eco Animal Health Ltd
Original Assignee
Cambridge University Technical Services Ltd CUTS
Eco Animal Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge University Technical Services Ltd CUTS, Eco Animal Health Ltd filed Critical Cambridge University Technical Services Ltd CUTS
Priority to GB0613952A priority Critical patent/GB0613952D0/en
Publication of GB0613952D0 publication Critical patent/GB0613952D0/en
Priority to RU2009104022/15A priority patent/RU2412710C2/en
Priority to JP2009518962A priority patent/JP5232781B2/en
Priority to CN2007800332202A priority patent/CN101511374B/en
Priority to DK07766205.4T priority patent/DK2043661T3/en
Priority to BRPI0714374-5A priority patent/BRPI0714374A2/en
Priority to EP07766205.4A priority patent/EP2043661B1/en
Priority to ES07766205.4T priority patent/ES2526817T3/en
Priority to PCT/GB2007/002620 priority patent/WO2008007104A1/en
Priority to KR1020097002909A priority patent/KR101413274B1/en
Priority to CA2657275A priority patent/CA2657275C/en
Priority to PL07766205T priority patent/PL2043661T3/en
Priority to US12/373,657 priority patent/US9066964B2/en
Priority to MX2009000393A priority patent/MX2009000393A/en
Priority to SI200731581T priority patent/SI2043661T1/en
Priority to PT77662054T priority patent/PT2043661E/en
Priority to CY20141101098T priority patent/CY1115847T1/en
Priority to US14/733,801 priority patent/US9649324B2/en
Ceased legal-status Critical Current

Links

GB0613952A 2006-07-13 2006-07-13 Antiviral agent Ceased GB0613952D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GB0613952A GB0613952D0 (en) 2006-07-13 2006-07-13 Antiviral agent
PT77662054T PT2043661E (en) 2006-07-13 2007-07-13 Use of tylvalosin as antiviral agent
PCT/GB2007/002620 WO2008007104A1 (en) 2006-07-13 2007-07-13 Use of tylvalosin as antiviral agent
CA2657275A CA2657275C (en) 2006-07-13 2007-07-13 Use of tylvalosin as antiviral agent
CN2007800332202A CN101511374B (en) 2006-07-13 2007-07-13 Use of tylvalosin as antiviral agent
DK07766205.4T DK2043661T3 (en) 2006-07-13 2007-07-13 USE OF TYLVALOSIN AS ANTIVIRAL AGENT
BRPI0714374-5A BRPI0714374A2 (en) 2006-07-13 2007-07-13 use of tilvalosin as antiviral agent
EP07766205.4A EP2043661B1 (en) 2006-07-13 2007-07-13 Use of tylvalosin as antiviral agent
ES07766205.4T ES2526817T3 (en) 2006-07-13 2007-07-13 Use of tilvalosin as an antiviral agent
RU2009104022/15A RU2412710C2 (en) 2006-07-13 2007-07-13 Application of tylvalosin as antiviral agent
KR1020097002909A KR101413274B1 (en) 2006-07-13 2007-07-13 Use of Tylvalosin as Antiviral Agent
JP2009518962A JP5232781B2 (en) 2006-07-13 2007-07-13 Use of tylvalosin as an antiviral agent
PL07766205T PL2043661T3 (en) 2006-07-13 2007-07-13 Use of tylvalosin as antiviral agent
US12/373,657 US9066964B2 (en) 2006-07-13 2007-07-13 Use of tylvalosin as antiviral agent
MX2009000393A MX2009000393A (en) 2006-07-13 2007-07-13 Use of tylvalosin as antiviral agent.
SI200731581T SI2043661T1 (en) 2006-07-13 2007-07-13 Use of tylvalosin as antiviral agent
CY20141101098T CY1115847T1 (en) 2006-07-13 2014-12-31 USE OF TYLVALOSIN AS ANTIQUE FACTOR
US14/733,801 US9649324B2 (en) 2006-07-13 2015-06-08 Use of tylvalosin as antiviral agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0613952A GB0613952D0 (en) 2006-07-13 2006-07-13 Antiviral agent

Publications (1)

Publication Number Publication Date
GB0613952D0 true GB0613952D0 (en) 2006-08-23

Family

ID=36955608

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0613952A Ceased GB0613952D0 (en) 2006-07-13 2006-07-13 Antiviral agent

Country Status (2)

Country Link
CN (1) CN101511374B (en)
GB (1) GB0613952D0 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114642641A (en) * 2022-05-24 2022-06-21 山东国邦药业有限公司 Tylosin tartrate water-soluble granules and preparation method thereof

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109700823B (en) * 2014-08-18 2021-07-06 中国医学科学院药物研究所 Application of telithromycin in resisting ebola virus infection
CN105477007B (en) * 2014-09-15 2020-02-18 中国医学科学院药物研究所 Application of macrolide medicine in resisting filovirus infection
CN107281210B (en) * 2016-04-11 2022-09-16 中国医学科学院药物研究所 Application of azithromycin in resisting coronavirus infection
CN107625779A (en) * 2017-10-19 2018-01-26 洛阳瑞华动物保健品有限公司 A kind of pharmaceutical preparation, kit for being used to suppress PRRS virus duplication
CN109833326A (en) * 2017-11-24 2019-06-04 苏州系统医学研究所 Macrolide antibiotics is blocking the application in influenza infection
CN109646435B (en) * 2019-01-11 2021-08-03 山东省农业科学院奶牛研究中心 Application of ertapenem sodium in preparation of medicine for preventing and treating infectious bovine rhinotracheitis
CN110693888B (en) * 2019-11-05 2022-12-06 山东省农业科学院奶牛研究中心 Application of cefradine as bovine enterovirus inhibitor
EP4098265A4 (en) * 2020-01-30 2024-03-13 Shenyang Fuyang Pharmaceutical Technology Co., Ltd. Use of acylated spiramycin in preparation of medicament for treating coronavirus infectious disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0025556D0 (en) * 2000-10-18 2000-12-06 Eco Animal Health Ltd Treatment and prophylaxis of disease and infections of pigs and poultry

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114642641A (en) * 2022-05-24 2022-06-21 山东国邦药业有限公司 Tylosin tartrate water-soluble granules and preparation method thereof
CN114642641B (en) * 2022-05-24 2022-07-26 山东国邦药业有限公司 Tylosin tartrate water-soluble granules and preparation method thereof

Also Published As

Publication number Publication date
CN101511374A (en) 2009-08-19
CN101511374B (en) 2012-07-04

Similar Documents

Publication Publication Date Title
GB0709791D0 (en) Antiviral agents
ZA200806756B (en) Hetero-bycyclic antiviral compounds
EP2062596A4 (en) Anti-tumor agent
EP2239264A4 (en) Antitumor agent
EP2050434A4 (en) Moisturizing agent
GB0707000D0 (en) Antiviral agents
HK1139857A1 (en) Wrinkling-preventing and-modifying agent
ZA200802813B (en) Antitumor agent
EP2236594A4 (en) Biofilm-removing agent
GB0605107D0 (en) Use
HK1116064A1 (en) Antitumor agent
EP2221057A4 (en) Sense-improving agent
GB0613952D0 (en) Antiviral agent
EP2062892A4 (en) Hypertension-ameliorating agent
GB0805264D0 (en) Antiviral agents
GB0803707D0 (en) Antiviral agent
EP2138172A4 (en) Anti-viral agent
GB0614034D0 (en) Antiviral compounds
EP2030629A4 (en) Lipid-metabolism-improving agent
PT2471559E (en) Antiviral method
GB0624105D0 (en) Use
EP2168955A4 (en) Sleep-improving agent
EP2060263A4 (en) Lipid-metabolism-ameliorating agent
EP2127675A4 (en) Antiviral agent
EP2172195A4 (en) Cholesterol-control agent

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)